Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study

Sept des 23 (30%) patients inclus dans cette étude ont présenté une amélioration ou une stabilisation de leur CVF 6 mois après l’introduction de rituximab..

Interestingly, we observed that the presence of OvCa + /CD45 – CTCs detected in protocol B was associated with low KRT5 and KRT7 gene expression levels in the paired primary

INTRODUCTION During the past decade, mass-spectrometry-based proteomics has become an essential tool in biological and clinical investigation.1,2 Most protein quantification

Les éléments de dépistage dans les centres de transfusion sont un entretien médical avant chaque don, afin d'exclure les donneurs présentant un facteur de

For lung cancer diagnosed at the metastatic stage, one-year and two-year survival was not associated with the population density of the municipality of residence.. Despite a

Information on prescription of innovative drugs from an associated database (FICHCOMP) was crossed with the population density of the municipality and a social deprivation index

Isolated cells from two different aorta samples were run in two arrays to screen for 850 human miRNAs: 92 miRNAs were detected in aneurysmal SMCs and M1 and M2 macrophages with 87

Background: The direct comparison of CA19.9, circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) using endoscopic ultrasound-guided fine needle aspiration (EUS-FNA)